Dr. Mohammad Isreb,Associate Professor
Information about Dr. Mohammad Isreb at the University of Bradford.
- School of Pharmacy & Medical Sciences
(Faculty of Life Sciences) - Email:
- m.isreb1@bradford.ac.uk
- Telephone:
- +44 1274 234762
Biography
2020- now: Senior Lecturer in Medicine Development and Pharmaceutical Sciences, University of Bradford, UK2010-2020: Lecturer, School of Pharmacy, University of Bradford, UK
2007-2011: Post-graduate research student, School of Pharmacy, University of Bradford, UK
2006-2007: Part Time Lab Supervisor, De Montfort University, Leicester, UK
2005-2006: Lecturer assistant, University of Aleppo, Syria
2005-2006: Pharmacist at Asia Pharmaceuticals (Sterile manufacturing), Aleppo Syria
2004-2005: Community pharmacist, Latakia, Syria
1999-2004: Undergraduate student, Faculty of Pharmacy and medical science, University of Petra, Amman, Jordan
Research
Film coating, Solid dispersion, Thermal and Mechanical analysis, Nanotechnology, Microfluidics, Solubility enhancement.Research supervision
Dr. Mohammad Isreb is responsible for the supervision of 1 postgraduate researchers at the University of Bradford.
Professional activities
Information about education, employment and areas of particular interest for Dr. Mohammad Isreb is as follows:
Employment
- Latakia, Syria - Community pharmacist in the year 2004 (specified as 01/01/2004)
- University of Aleppo, Syria - Lecturer assistant in the year 2005 (specified as 01/01/2005)
- De Montfort University, Leicester, UK - Part Time Lab Supervisor in the year 2006 (specified as 01/01/2006)
- University of Bradford, UK - Lecturer in the year 2010 (specified as 01/01/2010)
Education
- University of Petra - BSc (Hons)
- University of Bradford - Ph.D
Publications
There are 20 publications involving or that are attributed to Dr. Mohammad Isreb. They are listed as:
- book chapter (1)
- peer reviewed journal (19)
Book Chapter
| Title | Year | Publication name | Journal | Volume | Pages | Authors | Editors | ISSN | Publisher | DOI | Location |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Poly (DL-Lactic Acid) | 2017 | Handbook of Pharmaceutical Excipients | Handbook of Pharmaceutical Excipients | R. T. Forbes and M. Isreb | Pharmaceutical Press |
Peer Reviewed Journal
| Title | Year | Publication name | Journal | Volume | Pages | Authors | Editors | ISSN | Publisher | DOI | Location |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DNA Damage in Healthy Individuals and Respiratory Patients after Treating Whole Blood In vitro with the Bulk and Nano Forms of NSAIDs | 2016 | Najafzadeh, Mojgan; Normington, Charmaine; Jacob, B.K.; Isreb, Mohammad; Gopalan, Rajendran C.; Anderson, Diana | |||||||||
| Smart nanocrystals of artemether: fabrication, characterization, and comparative in vitro and in vivo antimalarial evaluation | 2016 | Shah, S.M.H.; Ullah, F.; Khan, Shahzeb; Shah, S.M.M.; de Matas, Marcel; Hussain, Z.; Minhas, M.U.; AbdEl-Salam, N.M.; Assi, Khaled H.; Isreb, Mohammad | |||||||||
| Aspirin and ibuprofen, in bulk and nanoforms: effects on DNA damage in peripheral lymphocytes from breast cancer patients and healthy individuals | 2018 | Dandah, Osama M.M.; Najafzadeh, Mojgan; Isreb, Mohammad; Linforth, R.; Tait, C.; Baumgartner, Adolf; Anderson, Diana | |||||||||
| In-process rheometry as a PAT tool for hot melt extrusion | 2018 | Kelly, Adrian L.; Gough, Timothy D.; Isreb, Mohammad; Dhumal, Ravindra S.; Jones, J.W.; Nicholson, S.; Dennis, A.B.; Paradkar, Anant R. | |||||||||
| Fabrication and characterization of dexibuprofen nanocrystals using dena® media milling | 2018 | Acta Farmaceutica Bonaerense | 37 | 947 - 952 | Khan J.;Bashir S.;Khan S.;Ihsan A.;Khan M.;Ali F.;Khan N.;Mkia A.;Mohammad M.;Isreb M. | 0326-2383 | |||||
| Nanonization and characterization of ketoprofen through microchannel fluidic reactor | 2018 | Acta Farmaceutica Bonaerense | 37 | 1149 - 1156 | Khan J.;Bashir S.;Khan S.;Ihsan A.;Khan A.;Shah S.;Khan B.;Khan N.;Ghafar R.;Isreb M. | 0326-2383 | |||||
| FABRICATION AND EVALUATION OF SMART NANOCRYSTALS OF ARTEMISININ FOR ANTIMALARIAL AND ANTIBACTERIAL EFFICACY | 2017 | African Journal Of Traditional, Complementary, And Alternative Medicines : Ajtcam | 14 | 251 - 262 | Shah S.;Ullah F.;Khan S.;Shah S.;Isreb M. | 2505-0044 | 10.21010/ajtcam.v14i1.27 | ||||
| Novel Ran-RCC1 inhibitory peptide-loaded nanoparticles have anti-cancer efficacy in vitro and in vivo | 2019 | Cancers | 11 | 222 | Haggag, Y.A.; Matchett, K.B.; Falconer, R.A.; Isreb, M.; Jones, J.; Faheem, A.; McCarron, P.; El-Tanani, Mohamed | 10.3390/cancers11020222 | |||||
| Fabrication and characterization of dexibuprofen nanocrystals using microchannel fluidic reactor | 2018 | Khan, J.; Bshir, S.; Khan, M.A.; Mohammad, Mohammad A.; Isreb, Mohammad | |||||||||
| Tablet fragmentation without a disintegrant: A novel design approach for accelerating disintegration and drug release from 3D printed cellulosic tablets | 2018 | Arafat, B.; Wojsz, M.; Isreb, A.; Forbes, R.T.; Isreb, Mohammad; Ahmed, W.; Arafat, T.; Alhnan, M.A. | |||||||||
| From ‘fixed dose combinations’ to ‘a dynamic dose combiner’: 3D printed bi-layer antihypertensive tablets | 2018 | Sadia, M.; Isreb, Abdullah; Abbadi, I.; Isreb, Mohammad; Aziz, D.; Selo, A.; Timmins, P.; Alhnan, M.A. | |||||||||
| 3D printed oral theophylline doses with innovative 'radiator-like' design: Impact of polyethylene oxide (PEO) molecular weight | 2019 | Isreb, A.; Baj, K.; Wojsz, M.; Isreb, Mohammad; Peak, M.; Alhnan, M.A. | |||||||||
| Enhanced dissolution rate of Ketoprofen by fabricating into smart nanocrystals | 2019 | Pakistan Journal of Pharmaceutical Sciences | 32 | 2899 - 2904 | Khan J.;Bashir S.;Khan M.;Ghaffar R.;Naz A.;Khan W.;Ahmad S.;Ullah A.;Ali F.;Isreb M. | 1011-601X | |||||
| Pluronic F127 thermosensitive injectable smart hydrogels for controlled drug delivery system development | 2020 | Journal of Colloid and Interface Science | 565 | 119 - 130 | Shriky B.;Kelly A.;Isreb M.;Babenko M.;Mahmoudi N.;Rogers S.;Shebanova O.;Snow T.;Gough T. | 0021-9797 | 10.1016/j.jcis.2019.12.096 | ||||
| An in vitro investigation into the protective and genotoxic effects of myricetin bulk and nano forms in lymphocytes of MGUS patients and healthy individuals | 2020 | Toxicology Letters | 327 | 33 - 40 | Akhtar S.;Najafzadeh M.;Isreb M.;Newton L.;Gopalan R.C.;Anderson D. | 0378-4274 | 10.1016/j.toxlet.2020.03.012 | ||||
| Ex vivo/in vitro protective effect of myricetin bulk and nano-forms on PhIP-induced DNA damage in lymphocytes from healthy individuals and pre-cancerous MGUS patients | 2020 | Archives of Toxicology | Akhtar S.;Najafzadeh M.;Isreb M.;Newton L.;Gopalan R.C.;Anderson D. | 0340-5761 | 10.1007/s00204-020-02754-x | ||||||
| ROS-induced oxidative damage in lymphocytes ex vivo/in vitro from healthy individuals and MGUS patients: protection by myricetin bulk and nanoforms | 2020 | Archives of Toxicology | Akhtar S.;Najafzadeh M.;Isreb M.;Newton L.;Gopalan R.C.;Anderson D. | 0340-5761 | 10.1007/s00204-020-02688-4 | ||||||
| Additive Manufacturing of a Point-of-Care “Polypill:” Fabrication of Concept Capsules of Complex Geometry with Bespoke Release against Cardiovascular Disease | 2020 | Advanced healthcare materials | Pereira B.C.;Isreb A.;Isreb M.;Forbes R.T.;Oga E.F.;Alhnan M.A. | 2192-2640 | 10.1002/adhm.202000236 | ||||||
| Co-delivery of a RanGTP inhibitory peptide and doxorubicin using dual loaded liposomal carriers to combat chemotherapeutic resistance in breast cancer cells. | 2020 | EXPERT OPINION ON DRUG DELIVERY | Haggag Y;Abu Ras B;El-Tanani Y;Tambuwala MM;McCarron P;Isreb M;El-Tanani M; | 1744-7593 | 10.1080/17425247.2020.1813714 |